Documents | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Documents

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Document Type

  • Publication (142)
  • Testimony (88)
  • Microgram (49)
  • DEA Administrator Remarks (29)
  • Speech (21)
  • In the News (5)
  • Announcements (3)

Publication Type

  • Intelligence (72)
  • DEA Administrator (39)
  • Forensics: Quality Management System Documents (32)
  • Drug Prevention (25)
  • Forensics (10)
  • Announcement (3)
  • Recruitment (1)

Drug Name

  • Narcóticos (opioides) (23)
  • Fentanyl (13)
  • Methamphetamine (10)
  • Drugs of Concern (7)
  • Heroin (7)
  • Cannabis (5)
  • Xylazine (5)
  • Marijuana (4)
  • Cocaine (2)
  • Synthetic Opioids (2)
  • Designer Drugs (1)
  • Hallucinogen (1)
  • Ketamine (1)
  • Spice/K2, Synthetic Marijuana (1)
  • Steroids (1)

Topic

  • Forensics: Quality Management System Documents (30)
  • Forensic Sciences (8)
  • Family (1)
  • Self Help/Personal Growth (1)
Clear All Results
340 Results - Showing 131 to 140
DOCUMENT
|
Publication

El cigarrillo electrónico y los concentrados de marihuana: ¿Qué es el “vapeo”?

Octubre 11, 2019
Spanish version of publication, Vaping and Marijuana Concentrates: What is Vaping? (October 2019).
Octubre 11, 2019
DOCUMENT
|
Publication

Vaping and Marijuana Concentrates: What is Vaping?

Octubre 11, 2019
Vaping is the act of inhaling and exhaling an aerosol or vapor made from a liquid or dry material that is heated in an electronic powered device, called an electronic cigarette, or e-cigarette. In addition to nicotine and flavored liquids, marijuana concentrates can also be vaped. This 6-panel, double-sided trifold...
Octubre 11, 2019
DOCUMENT
|
Publication

Drug Caused Deaths in the LA Field Division

Septiembre 19, 2019
The phenomenon of drug overdose death has grown steadily worse in the United States during most of the 21st century and has been skyrocketing since 2013 and the introduction of illicitly manufactured fentanyl-related substances into the domestic drug market...
Septiembre 19, 2019
DOCUMENT
|
Publication

Drug-Related Overdose Deaths in Pennsylvania, 2018 (BUL-132-19)

Septiembre 16, 2019
Since 2014, the Drug Enforcement Administration (DEA) Philadelphia Division Intelligence Program (PDIP) has annually collected and analyzed data and disseminated perceived trends and key findings that concern drug-related overdose deaths in Pennsylvania. This analysis has informed a multi-disciplinary audience relating to the drugs, populations, and geographic areas of greatest concern...
Septiembre 16, 2019
DOCUMENT
|
Testimony

Statement Before House of Representatives Subcommittee on "Oversight of Federal Efforts to Combat the Spread of Illicit Fentanyl"

Julio 16, 2019
Statement of Matthew Donahue before the House of Representatives, Energy and Commerce Committee, Subcommittee on Oversight and Investigations for a hearing entitled, Oversight of Federal Efforts to Combat the Spread of Illicit Fentanyl.
Julio 16, 2019
DOCUMENT
|
Testimony

Greg Cherundolo The Countdown: Fentanyl Analogues and the Expiring Emergency Scheduling Order

Junio 04, 2019
Greg Cherundolo Chief of Operations Office of Global Enforcement Drug Enforcement Administration U.S. Department of Justice before the United States Senate Judiciary Committee for hearing entitled: The Countdown: Fentanyl Analogues and the Expiring Emergency Scheduling Order.
Junio 04, 2019
DOCUMENT
|
Publication

Updating the Prescription Opioid Threat in Pennsylvania

Mayo 31, 2019
The Drug Enforcement Administration (DEA) Philadelphia Division’s Intelligence Program (PDIP) reviewed a set of data indicators for the years 2015-2018 to assess the current prescription opioid threat in Pennsylvania. Analysis revealed that a positive change in the prescription opioid threat may be underway...
Mayo 31, 2019
DOCUMENT
|
Testimony

Greg Cherundolo Unprecendented Migration at the U.S. Southern Border: Perspectives from the Frontline

Abril 09, 2019
Greg Cherundolo Chief of Operations Office of Global Enforcement Drug Enforcement Administration U.S. Department of Justice before the United States Senate Homeland Security and Governmental Affairs Committee
Abril 09, 2019
DOCUMENT
|
Speech

Acting Administrator Uttam Dhillon, Museum of Natural History and Science

Febrero 21, 2019
Acting Administrator Uttam Dhillon at the Drugs: Cost and Consequences Press Conference, Museum of Natural History and Science, Albuquerque, New Mexico
Febrero 21, 2019
DOCUMENT
|
Publication

Athletes and Opioids Poster

Febrero 19, 2019
What is prescription pain reliever misuse? As defined by the National Survey on Drug Use and Health, it’s “use without a prescription of one’s own or use at a higher dosage or more often than prescribed.” Prescription opioid addiction – stemming from misuse – has hit the nation hard in...
Febrero 19, 2019

Paginación

  • Primera página «
  • Anterior
  • Page 13
  • Current page 14
  • Page 15
  • Page 16
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster